| Antimicrobial resistance—a threat to the world’s sustainable development D Jasovský, J Littmann, A Zorzet, O Cars Upsala journal of medical sciences 121 (3), 159-164, 2016 | 443 | 2016 |
| Exploring the evidence base for national and regional policy interventions to combat resistance OA Dar, R Hasan, J Schlundt, S Harbarth, G Caleo, FK Dar, J Littmann, ... The Lancet 387 (10015), 285-295, 2016 | 211 | 2016 |
| The ethical significance of antimicrobial resistance J Littmann, AM Viens Public health ethics 8 (3), 209-224, 2015 | 176 | 2015 |
| Antibiotic resistance: an ethical challenge J Littmann, A Buyx, O Cars International journal of antimicrobial agents 46 (4), 359-361, 2015 | 117 | 2015 |
| Is antimicrobial resistance a slowly emerging disaster? AM Viens, J Littmann Public health ethics 8 (3), 255-265, 2015 | 110 | 2015 |
| The super-wicked problem of antimicrobial resistance J Littmann, AM Viens, DS Silva Ethics and drug resistance: Collective responsibility for global public …, 2020 | 48 | 2020 |
| National action to combat AMR: a One-Health approach to assess policy priorities in action plans A Ogyu, O Chan, J Littmann, HH Pang, X Lining, P Liu, N Matsunaga, ... BMJ Global Health 5 (7), e002427, 2020 | 39 | 2020 |
| Antimicrobial resistance and distributive justice JR Littmann UCL (University College London), 2014 | 26 | 2014 |
| Tackling anti-microbial resistance: ethical framework for rational antibiotic use J Littmann, A Rid, A Buyx The European Journal of Public Health 28 (2), 359-363, 2018 | 19 | 2018 |
| Lack of proportionality. Seven specifications of public interest that override post-approval commercial interests on limited access to clinical data D Strech, J Littmann Trials 13, 1-5, 2012 | 13 | 2012 |
| The contribution and attitudes of research ethics committees to complete registration and non-selective reporting of clinical trials: a European survey D Strech, J Littmann, OPEN consortium Research Ethics 12 (3), 123-136, 2016 | 12 | 2016 |
| Evaluation of the EC Action Plan against the rising threats from antimicrobial resistance E Smith, CA Lichten, J Taylor, C MacLure, L Lepetit, E Harte, A Martin, ... EU commission, 2016 | 12 | 2016 |
| How high is a high risk? Prioritising high-risk individuals in an influenza pandemic J Littmann Vaccine 32 (52), 7167-7170, 2014 | 11 | 2014 |
| Evaluation of the action plan against the rising threats from antimicrobial resistance: final report E Smith, CA Lichten, J Taylor, C MacLure, L Lepetit, E Harte, A Martin, ... European Commission, Directorate-General for Health and Food Safety …, 2016 | 10 | 2016 |
| Antimicrobial resistance is a super wicked problem J Littmann, GS Simonsen Tidsskrift for Den norske legeforening, 2019 | 8 | 2019 |
| Evaluating the risks of public health programs: Rational antibiotic use and antimicrobial resistance A Rid, J Littmann, A Buyx Bioethics 33 (7), 734-748, 2019 | 8 | 2019 |
| To overcome failure to publish negative findings: The OPEN project J Littmann, G Antes, D Strech, JJ Meerpohl Maturitas 76 (2), 111-112, 2013 | 8 | 2013 |
| Sustainable development levers are key in global response to antimicrobial resistance A Taylor, J Littmann, A Holzscheiter, M Voss, L Wieler, T Eckmanns The Lancet 394 (10214), 2050-2051, 2019 | 7 | 2019 |
| Antibiotikaresistenz. Ethische Aspekte einer drängenden Herausforderung J Littmann, B Buyx Ethik in der Medizin 27 (4), 301-314, 2014 | 4 | 2014 |
| Antimicrobial Resistance D Jasovský, J Littmann, A Zorzet, O Cars development dialogue 2, 2016 | 3 | 2016 |
